Want to see OFIX full AI Analyst Report?
Orthofix Medical (OFIX) Stock Statistics & Valuation Metrics
Total Valuation
Orthofix Medical has a market cap or net worth of $369.44M. The enterprise value is $531.38M.
- Market Cap
- $369.44M
- Enterprise Value
- $531.38M
Share Statistics
Orthofix Medical has 40,732,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 40,732,610
- Owned by Insiders
- 26.60%
- Owned by Institutions
- 27.47%
Financial Efficiency
Orthofix Medical’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -10.01%.
- Return on Equity (ROE)
- -0.20
- Return on Assets (ROA)
- -0.11
- Return on Invested Capital (ROIC)
- -10.01%
- Return on Capital Employed (ROCE)
- -0.10
- Revenue Per Employee
- 512.34K
- Profits Per Employee
- -57.44K
- Employee Count
- 1,605
- Asset Turnover
- 0.97
- Inventory Turnover
- 7.92
Valuation Ratios
The current PE Ratio of Orthofix Medical is -5.91. Orthofix Medical’s PEG ratio is -0.08.
- PE Ratio
- -5.91
- PS Ratio
- 0.44
- PB Ratio
- 0.86
- Price to FCF
- -13.56
- Price to Operating Cash Flow
- 21.76
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Orthofix Medical had revenue of 822.31M and earned -92.19M in profits. Earnings per share was -2.28.
- Revenue
- 822.31M
- Gross Profit
- 551.71M
- Operating Income
- -68.47M
- Pretax Income
- -90.81M
- Net Income
- -92.19M
- EBITDA
- 9.93M
- Earnings Per Share (EPS)
- -2.28
Cash Flow
In the last 12 months, operating cash flow was 17.05M and capital expenditures -44.08M, giving a free cash flow of -27.03M billion.
- Operating Cash Flow
- 17.05M
- Free Cash Flow
- -27.03M
- Free Cash Flow per Share
- -0.66
Dividends & Yields
Orthofix Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.37%
- Earnings Yield
- -16.64%
Stock Price Statistics
- Beta
- 0.95
- 52-Week Price Change
- -41.37%
- 50-Day Moving Average
- 9.39
- 200-Day Moving Average
- 11.06
- Relative Strength Index (RSI)
- 42.30
- Average Volume (3m)
- 388.08K
Important Dates
Orthofix Medical upcoming earnings date is Nov 09, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Nov 09, 2026
- Ex-Dividend Date
- ―
Financial Position
Orthofix Medical as a current ratio of 2.45, with Debt / Equity ratio of 50.94%
- Current Ratio
- 2.45
- Quick Ratio
- 2.24
- Debt to Market Cap
- 0.31
- Net Debt to EBITDA
- 14.82
- Interest Coverage Ratio
- -3.92
Taxes
In the past 12 months, Orthofix Medical has paid 1.38M in taxes.
- Income Tax
- 1.38M
- Effective Tax Rate
- -0.02
Enterprise Valuation
Orthofix Medical EV to EBITDA ratio is 5.43, with an EV/FCF ratio of -18.40.
- EV to Sales
- 0.60
- EV to EBITDA
- 5.43
- EV to Free Cash Flow
- -18.40
- EV to Operating Cash Flow
- 29.18
Balance Sheet
Orthofix Medical has $103.81M in cash and marketable securities with $234.62M in debt, giving a net cash position of -$130.81M billion.
- Cash & Marketable Securities
- $103.81M
- Total Debt
- $234.62M
- Net Cash
- -$130.81M
- Net Cash Per Share
- -$3.21
- Tangible Book Value Per Share
- $4.11
Margins
Gross margin is 69.59%, with operating margin of -3.05%, and net profit margin of -7.41%.
- Gross Margin
- 69.59%
- Operating Margin
- -3.05%
- Pretax Margin
- -7.24%
- Net Profit Margin
- -7.41%
- EBITDA Margin
- 11.00%
- EBIT Margin
- -4.55%
Analyst Forecast
The average price target for Orthofix Medical is $13.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $13.00
- Price Target Upside
- 43.33% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 2.99%
- EPS Growth Forecast
- 51.77%
Scores
- Smart Score
- 5
- AI Score
- 55